Every year we ask you to let your unit know your experience of care as a kidney patient. Your feedback is vital in influencing how your unit provides kidney care.
This year’s Kidney Patient Reported Experience Measure (PREM) is open from Monday 11 September until Monday 6 November 2023.
How can the PREM survey benefit me?
The survey can help you share your praise and concerns about the main areas of your care with your unit (anonymously). This helps your kidney team to understand how you and the other kidney patients they care for feel about your experience of care.
By taking part, you help your unit, other health care professionals, and kidney charities to get a national picture of people’s experience.
We can use this to identify where changes need to be made, and units can see how they are performing against other units, to make sure they aren’t falling behind.
Am I eligible to take part?
If you are over the age of 17 and living with chronic kidney disease (CKD), you can take part in the ADULT kidney PREM. This includes those attending a UK hospital renal unit or satellite unit but not yet on renal replacement therapy and anyone who has received a kidney transplant.
If you are a child/young person with CKD aged between 12 – 16 years old, you can complete the PAEDIATRIC kidney PREM. If you are a parent or carer of a child/young person of any age with CKD you can complete the PAEDIATRIC kidney PREM by proxy, answering in relation to the care your child receives.
Both surveys are available via the link at the top of this page, and can be accessed in English, Welsh, Urdu and Gujarati.
Where can I find out more about the PREM and the results for previous years?
Details of every previous PREM survey are available on our Kidney PREM hub.
Plans announced to introduce organ donatio...
NHS Blood and Transplant, the Department of Health and Social Care and the Home Office are working in partn...
Study of vulnerability to Covid-19 opens t...
Patient recruitment has opened for the Stratification of Clinically Vulnerable People for COVID-19 Risk Usi...